Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Breast Neoplasms 2Rectal Neoplasms 1Motor Activity 1Lung Neoplasms 1Hodgkin Disease 1Digestive System Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Brain Neoplasms 1

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Neuropsychological Tests 4Walking 3Memantine 3Tablets 2Standard of Care 2Patient Reported Outcome Measures 2Methods 2Electroencephalography 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lime 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Surveys and Questionnaires 1Sugars 1Sodium Chloride 1Sirolimus 1Silymarin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cognitive Dysfunction × Physical Conditioning, Human × Clear all
NCT03736460 2020-04-22

Cancer Related Cognitive Impairment After Chemotherapy: Evaluation of Potential Therapeutic Interventions

KU Leuven

Phase NA Unknown
120 enrolled

Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡